Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Kir6.1- and SUR2-dependent KATP overactivity disrupts intestinal motility in murine models of Cantú syndrome
Nathaniel W. York, Helen Parker, Zili Xie, David Tyus, Maham Akbar Waheed, Zihan Yan, Dorothy K. Grange, Maria Sara Remedi, Sarah K. England, Hongzhen Hu, Colin G. Nichols
Nathaniel W. York, Helen Parker, Zili Xie, David Tyus, Maham Akbar Waheed, Zihan Yan, Dorothy K. Grange, Maria Sara Remedi, Sarah K. England, Hongzhen Hu, Colin G. Nichols
View: Text | PDF
Research Article Gastroenterology Muscle biology

Kir6.1- and SUR2-dependent KATP overactivity disrupts intestinal motility in murine models of Cantú syndrome

  • Text
  • PDF
Abstract

Cantú syndrome (CS), caused by gain-of-function (GOF) mutations in pore-forming (Kir6.1, KCNJ8) and accessory (SUR2, ABCC9) ATP-sensitive potassium (KATP) channel subunit genes, is frequently accompanied by gastrointestinal (GI) dysmotility, and we describe 1 CS patient who required an implanted intestinal irrigation system for successful stooling. We used gene-modified mice to assess the underlying KATP channel subunits in gut smooth muscle and to model the consequences of altered KATP channels in CS gut. We show that Kir6.1/SUR2 subunits underlie smooth muscle KATP channels throughout the small intestine and colon. Knockin mice, carrying human KCNJ8 and ABCC9 CS mutations in the endogenous loci, exhibited reduced intrinsic contractility throughout the intestine, resulting in death when weaned onto solid food in the most severely affected animals. Death was avoided by weaning onto a liquid gel diet, implicating intestinal insufficiency and bowel impaction as the underlying cause, and GI transit was normalized by treatment with the KATP inhibitor glibenclamide. We thus define the molecular basis of intestinal KATP channel activity, the mechanism by which overactivity results in GI insufficiency, and a viable approach to therapy.

Authors

Nathaniel W. York, Helen Parker, Zili Xie, David Tyus, Maham Akbar Waheed, Zihan Yan, Dorothy K. Grange, Maria Sara Remedi, Sarah K. England, Hongzhen Hu, Colin G. Nichols

×

Figure 5

KATP GOF mutations do not affect intestinal contractile frequency but do alter pinacidil response.

Options: View larger image (or click on image) Download as PowerPoint
KATP GOF mutations do not affect intestinal contractile frequency but do...
(A) Representative recordings of tension in WT (black), SUR2AV/AV (red), and Kir6.1WT/VM (blue) ileal segments in the absence and presence of pinacidil, following the protocol shown in Figure 1. (B) Fourier analysis reveals no significant effect of CS mutations on contractile frequency in any segments of the small intestine or the colon (WT duodenum, jejunum, ileum, and colon; n = 13, 17, 19, and 12, respectively. SUR2AV/WT duodenum, jejunum, ileum, and colon; n = 4, 9, 7, and 10, respectively. SUR2AV/AV duodenum, jejunum, ileum, and colon; n = 10, 12, 15, and 9, respectively. Kir6.1WT/VM duodenum, jejunum, ileum, and colon; n = 10, 9, 13, and 11, respectively). (C) Pinacidil-response (relative tension) relationships for WT (black), SUR2AV/AV (red), and Kir6.1WT/VM (blue) duodenum, jejunum, and ileum, from experiments as above. SUR2WT/AV and SUR2AV/AV exhibit an increase in pinacidil-insensitive component of contraction, but Kir6.1WT/VM do not. For illustrative purposes, average dose-responses are fit with single sigmoidal curves. (D and E) Half maximal inhibitory concentration in CS (D), and pinacidil-insensitive contraction as a fraction of the contraction in zero pinacidil (E), for SUR2WT/AV (WT/AV) and SUR2AV/AV (AV/AV) segments. For C–E, WT duodenum, jejunum, ileum, and colon; n = 6, 5, 5, and 5, respectively. SUR2AV/WT duodenum, jejunum, ileum, and colon; n = 3, 3, 5, and 3, respectively. SUR2AV/AV duodenum, jejunum, ileum, and colon; n = 5, 6, 4, and 4, respectively. Kir6.1WT/VM duodenum, jejunum, ileum, and colon; n = 5, 3, 5, and 4 respectively). For all panels, significance was determined by 1-way ANOVA for each segment and post hoc Dunnett’s test, comparing each genotype with WT. Data are shown as mean ± SEM (*P < 0.05, **P < 0.01, ***P < 0.001).

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts